Mitigating Ischemic Injury of Stem Cell-Derived Insulin-Producing Cells after Transplant

The advent of large-scale in vitro differentiation of human stem cell-derived insulin-producing cells (SCIPC) has brought us closer to treating diabetes using stem cell technology. However, decades of experiences from islet transplantation show that ischemia-induced islet cell death after transplant...

Descripción completa

Detalles Bibliográficos
Autores principales: Faleo, Gaetano, Russ, Holger A., Wisel, Steven, Parent, Audrey V., Nguyen, Vinh, Nair, Gopika G., Freise, Jonathan E., Villanueva, Karina E., Szot, Gregory L., Hebrok, Matthias, Tang, Qizhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599226/
https://www.ncbi.nlm.nih.gov/pubmed/28803916
http://dx.doi.org/10.1016/j.stemcr.2017.07.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599226/
https://www.ncbi.nlm.nih.gov/pubmed/28803916
http://dx.doi.org/10.1016/j.stemcr.2017.07.012

Ejemplares similares